High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$916K
$916,618
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
2026-03-04
$301,920
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
|
2026-03-04 | $301,920 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-03
$3,690
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-03 | $3,690 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-25
$103,633x2
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-25 | $103,633x2 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -13.4%
2025-11-24
$101,475
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -13.4%
|
2025-11-24 | $101,475 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -38.3%
2025-10-09
$405,900
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -38.3%
|
2025-10-09 | $405,900 | S | Form 4 |